Back to search
FDAFDA · Food and drugs·Recall number D-0725-2016

risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC: 68382-156-06.

Published March 2, 2016 · Recall initiated: January 14, 2016

Summary

FDA records drug Class III recall D-0725-2016, published March 2, 2016 and initiated January 14, 2016. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 9504 Bottles; Lot: Lot #: MP4967, Expiry: 04/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification for a known degradant.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zydus Pharmaceuticals USA Inc
Distributor
US Nationwide including Puerto Rico
Lot
Lot #: MP4967, Expiry: 04/2016.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC: 68382-156-06. recalled?

Yes. FDA published recall D-0725-2016 on March 2, 2016. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification for a known degradant.

What should I do if I have this product?

Voluntary: Firm initiated · Letter